Koselugo Capsule
Product Images NDC 0310-0625

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Koselugo (NDC 0310-0625). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10_mg (10mgpdp)

Koselugo (selumetinib) 10 mg capsules label for oral use. The label indicates prescription-only status, with instructions to dispense in the original bottle and not to remove the desiccant. It also notes the package contains 28 capsules. The labeler is AstraZeneca Pharmaceuticals LP.*

FDA Label Image

25_mg (25mgpdp)

Koselugo (selumetinib) 25 mg capsules label for oral administration, manufactured by AstraZeneca Pharmaceuticals LP. The label includes storage instructions to keep the original bottle closed with the desiccant and indicates a package containing 28 capsules.*

FDA Label Image

Structure (Chemicalstructure Selumetinib)

Chemical structure of selumetinib sulfate, the active ingredient in KOSELUGO capsules by AstraZeneca Pharmaceuticals LP. The structure shows the molecular arrangement including hydroxyl, amide, halogen (chlorine, bromine, fluoride), and methyl groups as part of the compound complexed with sulfuric acid (H2SO4).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.